Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Legend Biotech (LEGN) EPS (Weighted Average and Diluted): 2019-2025

Historic EPS (Weighted Average and Diluted) for Legend Biotech (LEGN) over the last 3 years, with Sep 2025 value amounting to -$0.11.

  • Legend Biotech's EPS (Weighted Average and Diluted) rose 67.65% to -$0.11 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.65, marking a year-over-year increase of 37.00%. This contributed to the annual value of -$0.48 for FY2024, which is 67.35% up from last year.
  • According to the latest figures from Q3 2025, Legend Biotech's EPS (Weighted Average and Diluted) is -$0.11, which was up 60.71% from -$0.28 recorded in Q2 2025.
  • Over the past 5 years, Legend Biotech's EPS (Weighted Average and Diluted) peaked at $0.08 during Q4 2024, and registered a low of -$0.43 during Q3 2021.
  • In the last 2 years, Legend Biotech's EPS (Weighted Average and Diluted) had a median value of -$0.16 in 2024 and averaged -$0.16.
  • Per our database at Business Quant, Legend Biotech's EPS (Weighted Average and Diluted) skyrocketed by 69.23% in 2022 and then crashed by 75.00% in 2025.
  • Quarterly analysis of 4 years shows Legend Biotech's EPS (Weighted Average and Diluted) stood at -$0.31 in 2021, then plummeted by 36.23% to -$0.43 in 2022, then reached $0.08 in 2024, then soared by 67.65% to -$0.11 in 2025.
  • Its EPS (Weighted Average and Diluted) was -$0.11 in Q3 2025, compared to -$0.28 in Q2 2025 and $0.08 in Q4 2024.